TBIO News

Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress

(TBIO) Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress

Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights

August 13, 2025Earnings